Capital markets: equity offerings
Cyber law (including privacy and data protection)
Fintech
General commercial disputes
Healthcare: life sciences
International arbitration
Land use/zoning
Leading trial lawyers
M&A: middle-market ($500m-999m)
Patents: litigation (full coverage)
Patents: prosecution (including re-examination and post-grant proceedings)
Private equity funds (including venture capital)
Real estate
Securities litigation: defense
Technology transactions
Telecoms and broadcast: regulatory
Telecoms and broadcast: transactional
Trade secrets (litigation and non-contentious matters)
Trademarks: litigation
Trademarks: non-contentious (including prosecution, portfolio management and licensing)
US taxes: contentious
US taxes: non-contentious
Venture capital and emerging companies
Leading lawyers
Keith Berets
|
Technology transactions
|
Heidi Keefe
|
Patents: litigation (full coverage)
|
Charlie Kim
|
Capital markets: equity offerings
|
Alexander Lee
|
US taxes: non-contentious
|
Jamie Leigh
|
M&A: middle-market ($500m-999m)
|
David Peinsipp
|
Capital markets: equity offerings |
Mark Tanoury
|
Venture capital and emerging companies
|
Hall of Fame
Barbara Borden |
M&A: middle-market ($500m-999m) |
John Crittenden |
Trademarks: litigation |
Barbara Kosacz |
Healthcare: life sciences |
Fred Muto |
Venture capital and emerging companies |
Stephen Neal |
Leading trial lawyers |
Michael Rhodes |
Leading trial lawyers |
Adam Ruttenberg |
Technology transactions |
Next generation partners
Ben Beerle |
M&A: middle-market ($500m-999m) |
Kate Hillier |
Healthcare: life sciences |
Siana Lowrey |
Capital markets: equity offerings |
David Navetta |
Cyber law (including data privacy and data protection) |
Adriana Lofaro Wirtz |
US taxes: contentious |
Recommended Lawyers
Michael Attanasio
|
General commercial disputes
|
Michael Basile
|
Telecoms and broadcast: regulatory
Telecoms and broadcast: transactional
|
Mark Beckett
|
International arbitration
|
Laura Berezin |
Healthcare: life sciences |
Matthew Bartus |
Venture capital and emerging companies |
Philip Bowman |
General commercial disputes |
Matthew Brigham |
Patents: litigation (full coverage)
|
Matthew D. Brown
|
Media, technology and telecoms – Cyber law (including data privacy and data protection)
|
Alfred Browne |
Fintech |
Kay Chandler |
Healthcare: life sciences |
Adam Chase
|
Technology transactions
|
Reuben Chen |
Patents: litigation (full coverage) |
John Clendenin
|
Private equity funds (including venture capital) |
William Corcoran |
US taxes: non-contentious
|
John Dado |
Private equity funds (including venture capital)
|
Joseph Drayton
|
General commercial disputes
Patents: litigation (full coverage) |
Ivor Elrifi
|
Healthcare: life sciences
Patents: prosecution (including re-examination and post-grant proceedings) |
John Feore |
Telecoms and broadcast: regulatory
Telecoms and broadcast: transactional |
Koji Fukumura |
Securities litigation: defense |
Adam Gershenson |
Trade secrets (litigation and non-contentious matters) |
Bobby Ghajar |
Trademarks: litigation
Trademarks: non-contentious (including prosecution, portfolio management and licensing) |
Patrick Gibbs |
Securities litigation: defense |
Colleen Gillis |
Land use/zoning |
Shane Goudey |
Private equity funds (including venture capital) |
TJ Graham |
Technology transactions |
Jon Graves |
Patents: litigation (full coverage)
|
Div Gupta |
Capital markets: equity offerings |
Lila Hope |
Healthcare: life sciences |
Jack Lavoie |
Land use/zoning |
Travis LeBlanc |
Cyber law (including data privacy and data protection) |
Alan Levine |
General commercial disputes |
Mike Lincoln |
Venture capital and emerging companies |
Mark Looney |
Land use/zoning |
Mika Reiner Mayer
|
Healthcare: life sciences
Patents: prosecution (including re-examination and post-grant proceedings)
|
Robert McDowell |
Telecoms and broadcast: regulatory
Telecoms and broadcast: transactional
|
Lowell Mead |
Patents: litigation (full coverage)
|
Kevin Mills
|
Telecoms and broadcast: transactional
|
Patrick Mitchell |
Venture capital and emerging companies |
Phillip Morton |
Patents: litigation (full coverage)
|
Kathleen Pakenham |
US taxes: contentious
|
Nicole Peppe
|
Private equity funds (including venture capital)
|
Adam Pivovar |
Patents: litigation (full coverage)
|
Marya Postner |
Healthcare: life sciences |
Jason Rademacher |
Telecoms and broadcast: regulatory |
Marc Recht |
Healthcare: life sciences |
Michelle Rhyu |
Patents: litigation (full coverage)
|
Randy Sabett |
Cyber law (including data privacy and data protection) |
Ian Shapiro |
Trade secrets (litigation and non-contentious matters) |
Michael Sheetz |
Trade secrets (litigation and non-contentious matters) |
Jordan Silber |
Private equity funds (including venture capital)
|
Stephen Smith |
Patents: litigation (full coverage) |
Marc Suskin
|
International arbitration
|
Rachel Thorn
|
International arbitration
|
Mark Weeks |
Healthcare: life sciences |
Mark Weinstein |
Patents: litigation (full coverage)
|
Henry Wendel |
Telecoms and broadcast: regulatory
Telecoms and broadcast: transactional |
Dave Young
|
Venture capital and emerging companies |
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 1,100+ lawyers across 16 offices in the United States, Asia and Europe.